专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110064816A1 ATORVASTATIN COMPOSITIONS 审中-公开
标题翻译： ATORVASTATIN组合物
公开(公告)号：US20110064816A1
公开(公告)日：2011-03-17
申请号：US12992340
申请日：2009-05-13
申请人： Alagarsamy Alagumurugan , Rakesh Kumar Bhasin , Harshal Prabhakar Bhagwatwar , Rizwan Zafar , Saptarshi Nath , Ranadeep Paramananda Bokalial , Lakshmi Prasanna Gubbala , Venkata Nookaraju Sreedharala , Amarjit Maharaj Giri , Pradeep Jairao Karatgi , Sanjay Chhagan Wagh , Ravi Pillai , Kaushik Atul , Varghese Bency
发明人： Alagarsamy Alagumurugan , Rakesh Kumar Bhasin , Harshal Prabhakar Bhagwatwar , Rizwan Zafar , Saptarshi Nath , Ranadeep Paramananda Bokalial , Lakshmi Prasanna Gubbala , Venkata Nookaraju Sreedharala , Amarjit Maharaj Giri , Pradeep Jairao Karatgi , Sanjay Chhagan Wagh , Ravi Pillai , Kaushik Atul , Varghese Bency
IPC分类号： A61K9/14 , A61K31/40 , A61K9/00 , A61P9/10
CPC分类号： A61K31/40 , A61K9/1635 , A61K9/2018 , A61K9/205 , A61K9/2054 , A61K9/2086 , A61K9/2095 , A61K9/2866
摘要： Compositions containing atorvastatin, including its pharmaceutically acceptable salts, solvates, hydrates, enantiomers, polymorphs and their mixtures, and processes for preparing the same. Further aspects relate to pharmaceutical formulations comprising compositions containing atorvastatin, or a salt thereof, processes for preparing the same, and their methods of use, treatment and administration.
摘要翻译：含有阿托伐他汀的组合物，包括其药学上可接受的盐，溶剂合物，水合物，对映体，多晶型物及其混合物，及其制备方法。其它方面涉及含有阿托伐他汀或其盐的组合物，其制备方法及其使用方法，治疗和给药的药物制剂。

2. 发明申请

US20110009362A1 SOLUBILITY-ENHANCED FORMS OF APREPITANT AND PHARMACEUTICAL COMPOSITIONS THEREOF 审中-公开
标题翻译：可溶性增强剂及其药物组合物
公开(公告)号：US20110009362A1
公开(公告)日：2011-01-13
申请号：US12919331
申请日：2009-02-27
申请人： Mahendra Ramachandra Joshi , Nithya Radhakrishnan , Munish Kumar Dhiman , Pradeep Jairao Karatgi , Sanjay Chhagan Wagh , Raviraj Sukumar Pillai , Harshal Prabhakar Bhagwatwar , Venkata Nookaraju Sreedharala
发明人： Mahendra Ramachandra Joshi , Nithya Radhakrishnan , Munish Kumar Dhiman , Pradeep Jairao Karatgi , Sanjay Chhagan Wagh , Raviraj Sukumar Pillai , Harshal Prabhakar Bhagwatwar , Venkata Nookaraju Sreedharala
IPC分类号： A61K31/5377 , A61K31/724 , C08B30/18 , C07D413/06 , A61P1/08
CPC分类号： A61K31/53 , A61K9/0056 , A61K9/146 , A61K9/1623 , A61K9/1635 , A61K9/1652 , A61K9/1676 , A61K9/19 , A61K9/2018 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K47/40 , A61K47/6951 , B82Y5/00 , C08B37/0015 , C08J3/122 , C08L5/16 , C08L1/02 , C08L3/08 , C08L1/286 , C08L39/06
摘要： Solubility-enhanced forms of aprepitant and processes for preparing such forms. The invention also provides solubility-enhanced forms of aprepitant that also possess stability against solid state conversions. Certain solubility-enhanced forms of aprepitant comprise a cyclodextrin or any of its derivatives. Other solubility-enhanced forms of aprepitant comprise fine particle preparations of aprepitant. The invention further provides non-nanoparticulate pharmaceutical formulations prepared using solubility-enhanced forms of aprepitant. The invention also provides taste-masked and orally disintegrating pharmaceutical formulations comprising aprepitant. Further, pharmaceutical formulations comprising solubilityenhanced forms of aprepitant and processes of preparation of such formulations, as well as methods of using them are provided.
摘要翻译：阿司匹林的溶解性增强形式和制备此类形式的方法。本发明还提供还具有抵抗固态转化的稳定性的阿拉米特的溶解度增强形式。某些溶解性增强形式的阿瑞匹坦包含环糊精或其任何衍生物。其他溶解度增强形式的阿瑞匹坦剂包括阿米瑞明的细颗粒制剂。本发明进一步提供了使用阿维他啶的溶解度增强形式制备的非纳米颗粒药物制剂。本发明还提供包含阿维他啶的口味掩蔽和口腔崩解药物制剂。此外，提供了包含溶解度增强形式的阿拉米特的药物制剂及其制备方法，以及使用它们的方法。

3. 发明申请

US20100009955A1 PHARMACEUTICAL COMPOSITIONS OF CEFIXIME 有权
标题翻译： CEFIXIME的药物组合物
公开(公告)号：US20100009955A1
公开(公告)日：2010-01-14
申请号：US12297026
申请日：2007-03-23
申请人： Sanjay Chhagan Wagh , Bharat Raghunath Metkar , Makarand Krishnakumar Avachat , Himadri Sen
发明人： Sanjay Chhagan Wagh , Bharat Raghunath Metkar , Makarand Krishnakumar Avachat , Himadri Sen
IPC分类号： A61K31/546 , A61P31/04
CPC分类号： A61K9/10 , A61K9/0095 , A61K31/43 , A61K31/545 , A61K31/546 , Y10S514/97
摘要： A pharmaceutical suspension formulation comprising a dose greater than 100 mg/5 ml Cefixime and pharmaceutically acceptable excipients.
摘要翻译：包含剂量大于100mg / 5ml的头孢克肟和药学上可接受的赋形剂的药物悬浮液制剂。

4. 发明授权

US08900637B2 Stable taste masked formulations of cephalosporins 有权
标题翻译：头孢菌素的稳定口罩掩蔽制剂
公开(公告)号：US08900637B2
公开(公告)日：2014-12-02
申请号：US12095767
申请日：2005-12-02
申请人： Sachin Pundlik Kolhe , Subrata Kundu , Sanjay Chhagan Wagh , Makarand Krishnakumar Avachat , Himadri Sen
发明人： Sachin Pundlik Kolhe , Subrata Kundu , Sanjay Chhagan Wagh , Makarand Krishnakumar Avachat , Himadri Sen
IPC分类号： A61K9/16 , A61K31/00 , A61K9/28
CPC分类号： A61K31/00 , A61K9/1635 , A61K9/2886
摘要： A stable taste masked, pharmaceutical composition comprising a plurality of coated, non-disintegrating discrete dosage units, said units comprising of a core comprising one or more cephalosporins such as cefuroxime axetil and cefpodoxime proxetil and one or more coating layers. Cefuroxime axetil is in α-crystalline and amorphous forms, where at least 30% of the Cefuroxime axetil is in the α-crystalline form, wherein the particle size distribution of the α-crystalline form being such that 100% of the particles have a particle size below 250μ. The ratio of the crystalline fraction to the amorphous fraction ranges from 0.3:0.7 to 0.99:0.01. The particle size of cefpodoxime proxetil is such that 90% of the particles are below 15μ. The process of preparation of coated, non-disintegrating pellets comprising the steps of reducing the particle size of the one or more cephalosporins, blending with the other excipients, wet granulation, extrusion, spheronization, drying and screening to obtain pellets, said pellets being further coated with one or more layers of film coating to achieve taste masking.
摘要翻译：稳定的掩味的药物组合物，其包含多个涂覆的，不分散的离散剂量单位，所述单元由包含一种或多种头孢菌素如头孢呋辛酯和头孢泊肟酯的核心和一个或多个涂层组成。头孢呋辛酯是α-晶型和无定形形式，其中至少30％的头孢呋辛酯为α-结晶形式，其中α-晶型的粒度分布使得100％的颗粒具有颗粒尺寸低于250μ。结晶部分与无定形部分的比例为0.3:0.7至0.99:0.01。头孢泊肟酯的粒径使得90％的颗粒小于15μ。包衣，非崩解丸剂的制备方法包括以下步骤：减少一种或多种头孢菌素的粒度，与其它赋形剂混合，湿法制粒，挤出，滚圆，干燥和筛选以获得丸粒，所述丸粒进一步涂覆一层或多层薄膜包衣以达到掩味。

5. 发明申请

US20090022809A1 STABLE TASTE MASKED FORMULATIONS OF CEPHALOSPORINS 有权
标题翻译： CEPHOLOSPORINS的稳定的药物掩蔽配方
公开(公告)号：US20090022809A1
公开(公告)日：2009-01-22
申请号：US12095767
申请日：2005-12-02
申请人： Sachin Pundlik Kolhe , Subrata Kundu , Sanjay Chhagan Wagh , Makarand Krishnakumar Avachat , Himadri Sen
发明人： Sachin Pundlik Kolhe , Subrata Kundu , Sanjay Chhagan Wagh , Makarand Krishnakumar Avachat , Himadri Sen
IPC分类号： A61K9/16
CPC分类号： A61K31/00 , A61K9/1635 , A61K9/2886
摘要： A stable taste masked, pharmaceutical composition comprising a plurality of coated, non-disintegrating discrete dosage units, said units comprising of a core comprising one or more cephalosporins such as cefuroxime axetil and cefpodoxime proxetil and one or more coating layers. Cefuroxime axetil is in α-crystalline and amorphous forms, where at least 30% of the Cefuroxime axetil is in the α-crystalline form, wherein the particle size distribution of the α-crystalline form being such that 100% of the particles have a particle size below 250μ. The ratio of the crystalline fraction to the amorphous fraction ranges from 0.3:0.7 to 0.99:0.01. The particle size of cefpodoxime proxetil is such that 90% of the particles are below 15μ. The process of preparation of coated, non-disintegrating pellets comprising the steps of reducing the particle size of the one or more cephalosporins, blending with the other excipients, wet granulation, extrusion, spheronization, drying and screening to obtain pellets, said pellets being further coated with one or more layers of film coating to achieve taste masking.
摘要翻译：稳定的掩味的药物组合物，其包含多个涂覆的，不分散的离散剂量单位，所述单元由包含一种或多种头孢菌素如头孢呋辛酯和头孢泊肟酯的核心和一个或多个涂层组成。头孢呋辛酯是α-晶型和无定形形式，其中至少30％的头孢呋辛酯为α-晶型，其中α-晶形的粒度分布使得100％的颗粒具有颗粒尺寸在250mu以下。结晶部分与无定形部分的比例为0.3:0.7至0.99:0.01。头孢泊肟酯的粒径使得90％的颗粒小于15mu。包衣，非崩解丸剂的制备方法包括以下步骤：减少一种或多种头孢菌素的粒度，与其它赋形剂混合，湿法制粒，挤出，滚圆，干燥和筛选以获得丸粒，所述丸粒进一步涂覆一层或多层薄膜包衣以达到掩味。

6. 发明授权

US09241905B2 Pharmaceutical compositions of Cefixime 有权
标题翻译：头孢克肟的药物组合物
公开(公告)号：US09241905B2
公开(公告)日：2016-01-26
申请号：US12297026
申请日：2007-03-23
申请人： Sanjay Chhagan Wagh , Bharat Raghunath Metkar , Makarand Krishnakumar Avachat , Himadri Sen
发明人： Sanjay Chhagan Wagh , Bharat Raghunath Metkar , Makarand Krishnakumar Avachat , Himadri Sen
IPC分类号： A61K31/546 , A61K9/10 , A61K9/00 , A61K31/43 , A61K31/545
CPC分类号： A61K9/10 , A61K9/0095 , A61K31/43 , A61K31/545 , A61K31/546 , Y10S514/97
摘要： A pharmaceutical suspension formulation comprising a dose greater than 100 mg/5 ml Cefixime and pharmaceutically acceptable excipients.
摘要翻译：包含剂量大于100mg / 5ml的头孢克肟和药学上可接受的赋形剂的药物悬浮液制剂。

7. 发明申请

US20100260842A1 PSEUDOEPHEDRINE PHARMACEUTICAL FORMULATIONS 审中-公开
标题翻译：精神病药物制剂
公开(公告)号：US20100260842A1
公开(公告)日：2010-10-14
申请号：US12755374
申请日：2010-04-06
申请人： Rashmi Nair , Praveen Raheja , Sanjay Chhagan Wagh , Raviraj Sukumar Pillai
发明人： Rashmi Nair , Praveen Raheja , Sanjay Chhagan Wagh , Raviraj Sukumar Pillai
IPC分类号： A61K9/28 , A61K9/14 , A61K31/137 , A61P11/02 , A61P11/14 , A61P11/00
CPC分类号： A61K9/209 , A61K31/137
摘要： Controlled-release pharmaceutical formulations comprising pseudoephedrine or any of its pharmaceutically acceptable salts, processes for preparing the pharmaceutical formulations, and methods of using the formulations.
摘要翻译：包含伪麻黄素或其任何药学上可接受的盐的控制释放药物制剂，制备药物制剂的方法和使用该制剂的方法。

8. 发明申请

US20090197855A1 PHARMACEUTICAL COMPOSITIONS OF CEFDINIR 审中-公开
标题翻译： CEFDINIR的药物组合物
公开(公告)号：US20090197855A1
公开(公告)日：2009-08-06
申请号：US12299280
申请日：2007-03-08
申请人： Makarand Krishnakumar Avachat , Sanjay Chhagan Wagh , Nital Arvind Jugade
发明人： Makarand Krishnakumar Avachat , Sanjay Chhagan Wagh , Nital Arvind Jugade
IPC分类号： A61K31/546 , A61P31/04
CPC分类号： A61K9/0056
摘要： A chewable tablet dosage form comprising Cefdinir or pharmaceutically acceptable salts thereof for the oral administration of Cefdinir in a manner that is more palatable and less objectionable to population group's especially young children and older patients. A method of preparing the chewable tablets comprising Cefdinir and method of treatment using the same.
摘要翻译：一种咀嚼片剂剂型，其包含头孢地尼或其药学上可接受的盐，以口服给药头孢地尼，以更可口的方式，并且对人群特别是幼儿和老年患者的反感较差。制备包含头孢地尼的咀嚼片的方法和使用该咀嚼片的治疗方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式